Authorized representative profileBeauty Indicators International Limited
Taiwan高雄市美濃區合和里美中路8號2樓4 products representedJan 04, 2019 – Feb 21, 2019
VerifiedTFDA · Taiwan Food and Drug Administration registry
4
Products represented
2
Manufacturers
4
Active products
Feb 2019
Latest registration
Company details
- Address
- 高雄市美濃區合和里美中路8號2樓
- Authorization Code
- 59411514
Regulatory footprint
Search Beauty Indicators International Limited across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRecent registrations
Latest 5 products represented by this organization
Most popular products
Products with most registrations
Represented manufacturers
Manufacturers whose products are represented by this organization
Recent represented products
Most recent products (showing top 20)
VILLEA Soft Contact Lens
Registered: Feb 21, 2019 • Expires: Feb 21, 2024
- Risk Class
- Class 2
- Type
- MD
- Manufacturer
- B.S. CORPORATION
PEONY Soft Contact Lens
Registered: Feb 21, 2019 • Expires: Feb 21, 2024
- Risk Class
- Class 2
- Type
- MD
- Manufacturer
- B.S. CORPORATION
JENNYBEE Soft Contact Lens
Registered: Jan 04, 2019 • Expires: Jan 04, 2029
- Risk Class
- Class 2
- Type
- MD
- Manufacturer
- Lensmam Co., Ltd
JENNYBEE Soft Contact Lens
Registered: Jan 04, 2019 • Expires: Jan 04, 2029
- Risk Class
- Class 2
- Type
- MD
- Manufacturer
- Lensmam Co., Ltd
About this profile
Explore comprehensive authorized representative profile for Beauty Indicators International Limited through Pure Global AI's free Taiwan medical device database. This authorized representative handles 4 product registrations across 2 manufacturers and 3 unique product types. Their regulatory history spans from Jan 04, 2019 to Feb 21, 2019.
This page provides detailed insights including 4 recent product registrations, 3 most popular products with JENNYBEE Soft Contact Lens having 2 registrations, and 2 represented manufacturers including B.S. CORPORATION. Pure Global AI offers free access to Taiwan's medical device database, enabling global MedTech companies to analyze market dynamics and identify opportunities.